Search

everythinglearnresearchcommunity

for

Search:↓

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Hair microRNAs could be effective biomarkers for diagnosing scleroderma.

Scleroderma patients have lower hair miR-29a levels.

Surgical removal of a rare ovarian tumor improved symptoms and hormone levels in a postmenopausal woman.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Minoxidil effectively controls blood pressure in severe cases, but may cause fluid retention and edema.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Low zinc levels might be linked to worse outcomes in various skin disorders.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

Deep phenotyping helps distinguish between xeroderma pigmentosum and trichothiodystrophy, aiding in diagnosis and treatment.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.

Oral Apremilast effectively treats alopecia areata in most patients.

Examining nail biopsies is useful for diagnosing nail diseases.

The MPV/PC ratio can help assess disease activity in alopecia areata.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Eating disorders like anorexia and bulimia cause skin problems, and dermatologists can help detect these disorders early for better treatment outcomes.